Government Archives - Page 36 of 268

2 minute read

Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies

January 30, 3:31 PM

New IRS program launching for free tax filing could affect tax prep companies like H&R Block and Intuit. Market share drop could impact ETFs.

CERT

3 minute read

AI Growth, Lower Interest Rates Foil Recession Threats In 2024, Says IMF

By Neil Dennis

January 30, 1:51 PM

Fears of a severe economic downturn are fading as economic growth continues to outpace expectations. The U.S. economy is likely to grow by 2.1% in 2024 says International Monetary Fund.

BOTZ

2 minute read

Medicare’s Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%

By Vandana Singh

January 30, 12:37 PM

Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.

AZN

2 minute read

China Market Collapse Resumes As Government Fails To Put Brakes On Stock Dump

By Neil Dennis

January 30, 10:55 AM

Political, not economic, concerns are weighing most on China's equity markets

BABA

2 minute read

Pentagon’s Weapons Wish List Stalled As Defense Contractors Balk At Rising Costs: Report

By Benzinga Neuro

January 30, 8:50 AM

Despite a surge in orders from the U.S. and its allies for military equipment, defense contractors are hesitant to take on projects with high potential for cost overruns.

LHX

1 minute read

NioCorp Collaborated with Leading UK-Based Research University to Develop Innovative Aluminum-Scandium Alloys for the Automotive Sector

By Benzinga Newsdesk

January 30, 8:04 AM

NioCorp Developments Ltd. ("NioCorp" or the "Company") (NASDAQ:NB)(TSX:NB) is pleased to announce that the Company has entered into an agreement with London-based Brunel University London, a

1 minute read

Regulatory Applications Accepted in the US and Japan for Bristol Myers Squibb’s Breyanzi (Lisocabtagene Maraleucel) in Relapsed or Refractory Follicular Lymphoma (FL) and Relapsed or Refractory Mantle Cell Lymphoma (MCL)

By Benzinga Newsdesk

January 30, 8:00 AM

Bristol Myers Squibb (NYSE:BMY) today announced three regulatory acceptances from the U.S. Food and Drug Administration (FDA) and Japan's Ministry of Health, Labour and Welfare (MHLW)

BMY